In vitro and in vivo characterisation of piroxicam-loaded dika wax lipospheres

Tropical Journal of Pharmaceutical Research

Volumn 12, Issue 1, 2013, Pages 33-38

  Brown, Sinye A ^a   Chime, Salome A ^b   Attama, Anthony A ^b   Agu, Confidence I ^b   Onunkwo, Godswill C ^b  

^a UNIVERSITY OF PORT HARCOURT   (Nigeria)

^b UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Anti inflammatory; Dika wax; Lipospheres; Phospholipid; Piroxicam; Ulcerogenicity

Indexed keywords

DIKA WAX LIPOSPHERE; DRUG CARRIER; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PIROXICAM; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; ENCAPSULATION; FEMALE; HOMOGENATE; HOMOGENIZATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLUID; MALE; MICROPHOTOGRAPHY; NONHUMAN; PARTICLE SIZE; PAW EDEMA; PH; RAT; SIMULATION; ULCEROGENESIS; WISTAR RAT;

EID: 84874393275     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Attama AA, Okafor CE, Builders PF, Okorie O. Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium. J Drug Deliv 2009; 16:448-616.
2. Attama AA, Nkemnele MO. In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus. Int J Pharm 2005; 304: 4-10.
3. Ofoefule SI, Chukwu A, Okore VC, Ugwah MO. Use of dika fat in the formulation of sustained release frusemide encapsulated granules. Boll Chim Farm 1997; 136(10): 646-650.
4. Okorie VC. Effect of dika fat content of a barrier film coating on the kinetics of drug release from swelling polymeric systems. Boll Chim Farm 2000; 139(1): 21-25.
5. Reithmeier HJ, Herrmann and Gopferich A. Development and characterisation of lipid microparticles as a drug carrier for somatostatin. Int J Pharm 2001; 218: 133-143.
6. Rawat M, Saraf S. Liposphere: Emerging carries in delivery of proteins and peptides. Int. J Pharm Sci Nano 2008; 1(3): 207-214.
7. Domb AJ, Maniar M, Manoj. Liposphere for controlled delivery of substances. Eurpean Patent 1996; EP0502119.
8. Matos L, Nzikou JM, Pandzou-Yembe VN, Mapepoulou TG, Linder M, Desobrg S. Studies of Irvingia gabonensis seed kernels: Oil technological applications. Pak J Nutri 2009; 8(2): 151-157.
9. Cortesi R, Esposita E, Luca G, Nastruzzi C. Production of lipospheres as carries for bioactive compounds. Biomaterials 2003; 23: 2283-2294.
10. Winter ER, Risley EA, Nuss GU. Carrageenan-induced oedema in hind paw of rats as an assay for antiinflammatory drugs. Proc Soc Exp Bio Med 1962; 111: 544-547.
11. Winter EA, Risley EA, Nuss GU. Anti-inflammatory and antipyretic activities of indomethacin. J Pharm Exp Ther 1963; 141: 367-376.
12. Anosike A.C., Onyechi O., Ezeanyika L.U.S. and Nwuba M.M. (2009). Anti-inflammatory and anti-ulcerogenic activity of the ethanol extract of ginger (Zingiber officinale). Africa J. Biochemistry Res. 3(12); 379-384.
13. Parez GRM. Anti-inflammatory activity of Ambrosia artemisaefolia and Rheo spathacea. Phytomed 1996; 3(2): 163-167.
14. Chung-Chin M, Santos JL, Oliveira EV, Blaul, Menegon RF, Peccinini RG. Synthesis, ex-vivo and in vitro hydrolysis study of an indoline derivative designed as anti-inflammatory with reduced gastric ulceration properties. Molecules 2009; 14: 3187-3197.
15. Barakat SN and Yassin EB. In vitro characterisation of carbamazepine-loaded precifac lipospheres. Drug Del 2006; 13: 95-104.
16. Joseph N, Lakshims, Jayakrishnan A. A floating-type oral dosage form for piroxicam based on hollow polycarbonat microspheres; in vitro and in vivo evaluation in rabbits. J Control Rel 2002; 79:71-79.
17. Lichtenberger LM. The hydrophobic barrier properties of gastrointestinal mucus. Ann Rev Physio 1995; 57: 565-583.